Indirect Bilirubin

If you have seen this number on a liver panel, a high reading probably made you nervous. For most healthy adults it should not. A mild isolated high indirect bilirubin is usually a harmless inherited quirk, and it tends to travel with a lower risk of heart disease, not a higher one.

A persistently low reading deserves a second look for a different reason: several human studies link low bilirubin, often total bilirubin rather than indirect bilirubin itself, with higher cardiovascular risk. A single value tells you less than a pattern.

What This Number Actually Measures

Indirect bilirubin is the unconjugated form of bilirubin. It is made when immune cells in your spleen and liver dismantle worn-out red blood cells. The pigment travels through blood attached to albumin. Albumin is a carrier protein. In this form bilirubin does not dissolve in water, so it cannot pass into urine. It has to reach the liver first.

In the liver, UGT1A1 attaches a sugar to the pigment and turns it into direct bilirubin. Direct bilirubin can dissolve in water and leave through bile. Labs usually do not measure indirect bilirubin directly. They measure total and direct bilirubin, then subtract. So your indirect number reflects two things at once: how fast you are breaking down red blood cells, and how well your liver is processing the pigment.

The Heart Disease Connection

The useful surprise is that a liver-panel number can also mark cardiovascular risk. The relationship is not linear. Risk looks lowest at moderate bilirubin levels and higher at both ends, with low bilirubin carrying much of the extra risk in several cohorts.

In the Dongfeng-Tongji cohort, which looked at indirect bilirubin specifically, people in the middle of the indirect-bilirubin range had lower coronary heart disease risk than those at the bottom. Direct bilirubin behaved differently and rose with risk. Larger studies mostly measured total bilirubin, not indirect bilirubin; use them as supporting evidence, not a perfect match. In a 130,052-person statin-treated cohort, people whose total bilirubin sat near the bottom had about 18% higher cardiovascular risk, 34% higher heart attack risk, and 33% higher risk of dying from any cause than those around the middle. Among 4,303 adults over 60, the lowest-bilirubin group had the highest death rate over about four and a half years, roughly a third higher than a mid-range group. A meta-analysis of total bilirubin found that each standard step higher tracked with about 7% lower cardiovascular risk, while a later dose-response meta-analysis found a U-shape, with lowest risk at moderate levels.

This runs against the reflex that a liver-panel number going up is bad. Indirect bilirubin is not a good-number-bad-number marker in the way LDL cholesterol is. Bilirubin acts like a built-in antioxidant. Antioxidants help limit chemical wear inside cells. At mildly higher levels, especially when the rise is isolated and indirect, bilirubin may reflect more of that protection rather than a sick liver. Very high levels are a separate story; they can point to fast red cell breakdown or liver or bile duct disease.

When Higher Is Inherited

The most common reason for a mildly high indirect bilirubin with otherwise normal liver enzymes is Gilbert syndrome. It is a benign inherited variant in the UGT1A1 enzyme that affects about 3 to 7% of Americans. The enzyme works at reduced capacity, so the pigment builds up a little, especially during fasting, illness, dehydration, menstruation, or strenuous exercise. A severe calorie cut can raise unconjugated bilirubin two to threefold in people with Gilbert syndrome.

If anything, carrying it looks like a mild advantage. People with Gilbert syndrome have lower rates of coronary and peripheral artery disease, which fits the same antioxidant story behind the heart-disease findings above. That does not make Gilbert syndrome a treatment. For liver health, the finding is usually reassurance. It can matter if you are prescribed a drug that depends on UGT1A1, such as atazanavir.

When It Signals Red Blood Cell Breakdown

The other main reason indirect bilirubin rises is that red blood cells are being destroyed faster than usual. This is called hemolysis. It can show up in conditions like sickle cell disease, hereditary spherocytosis, and G6PD deficiency.

The way to tell hemolysis from the harmless inherited kind is not the bilirubin number alone. Use the companion labs. A low haptoglobin, a high reticulocyte count, and a high LDH point toward red cell breakdown. Reticulocytes are young red cells your marrow releases when it is trying to keep up. Indirect bilirubin is a better flag for slow, spleen-based hemolysis than for fast hemolysis inside blood vessels, which can sometimes look quieter on this test.

Cancer Signals Cut Both Ways

The cancer picture is mixed and depends on the site and on sex, so no single direction applies. In a Korean cohort, people in the highest third of bilirubin had about 26% lower colorectal cancer risk, with a U-shape in men. A European study that measured unconjugated bilirubin directly found the split more sharply: higher levels went with modestly higher colorectal cancer risk in men but lower risk in women.

One consistent exception is liver cancer, where higher bilirubin tracks with higher risk, because a struggling liver can raise bilirubin and raise cancer risk at the same time. That is a marker of an already sick liver, not proof that bilirubin causes cancer. For someone with normal liver enzymes, these cancer associations are too small and too inconsistent to act on by themselves.

Why One Reading Can Fool You

Start here before you read anything into a single result. Bilirubin is one of the more variable common lab values, and indirect bilirubin adds calculation noise because it is derived from total and direct bilirubin. The same person retested about two and a half weeks later can swing by roughly a quarter on average. In one large study, 38% of people with an initially high bilirubin came back normal on a repeat draw. A high number by itself often means nothing more than the day you drew it.

Reduced calorie intake can raise unconjugated bilirubin within a day or two, especially in Gilbert syndrome. Acute illness, dehydration, menstruation, and strenuous exercise can also push a Gilbert-pattern result higher. Bilirubin follows a daily rhythm, peaking in the morning after normal sleep, which is why a consistent morning draw makes results easier to compare.

A few medicines shift the number without meaning your liver is damaged. Atazanavir can raise indirect bilirubin substantially by slowing bilirubin processing and transport, without harming the liver. Statins can nudge total bilirubin up by changing liver transport, and corticosteroids can push bilirubin down. These are context, not diagnoses.